Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC5A7 | Q9GZV3 | 5/20 | 0.35 |
| ▸ | BCL9 | O00512 | 8/20 | 0.35 |
| ▸ | CTNNB1 | P35222 | 8/20 | 0.35 |
| ▸ | PDE4A | P27815 | 3/20 | 0.34 |
| ▸ | PDE4B | Q07343 | 3/20 | 0.34 |
| ▸ | PDE4C | Q08493 | 3/20 | 0.34 |
| ▸ | PDE4D | Q08499 | 3/20 | 0.34 |
| ▸ | EPHX2 | P34913 | 2/20 | 0.34 |
| ▸ | ENPP2 | Q13822 | 2/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24363881 | 0.96 | SLC5A7 (0.38) | SLC5A7PDE4APDE4BPDE4CPDE4D | |
| SCHEMBL23685130 | 0.92 | SLC5A7 (0.38) | SLC5A7PDE4APDE4BPDE4CPDE4D | |
| SCHEMBL23685207 | 0.92 | SLC5A7 (0.38) | SLC5A7PDE4APDE4BPDE4CPDE4D | |
| SCHEMBL23683769 | 0.91 | SLC5A7 (0.39) | SLC5A7PDE4APDE4BPDE4CPDE4D | |
| SCHEMBL23685128 | 0.88 | AR (0.35) | SLC5A7 | |
| SCHEMBL23685102 | 0.88 | SLC5A7 (0.40) | SLC5A7PDE4APDE4BPDE4CPDE4D | |
| SCHEMBL23685097 | 0.87 | SLC5A7 (0.41) | SLC5A7PDE4APDE4BPDE4CPDE4D | |
| SCHEMBL23683777 | 0.86 | SLC5A7 (0.39) | SLC5A7PDE4APDE4BPDE4CPDE4D | |
| SCHEMBL24363595 | 0.86 | SLC5A7 (0.38) | SLC5A7PDE4APDE4BPDE4CPDE4D | |
| SCHEMBL24346378 | 0.86 | SLC5A7 (0.38) | SLC5A7PDE4APDE4BPDE4CPDE4D |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2021150806-A1 | HETEROCYCLIC COMPOUNDS AS ANTI-VIRAL AGENTS | ENANTA PHARMACEUTICALS, INC. (US) | 2021-07-29 | — | — | WO | disclosed |